Pharmaceuticals, Biotechnology and Life Sciences
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation...
Bora Pharmaceutical Services Inc., a division of Bora Pharmaceuticals, has announced that its Mississauga, Ontario contract manufacturing and packaging facility has successfully completed its first Health Canada inspection since being aquired by...
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy...
Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small...
An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....
Biopharma company prepares for launch of first US product CLONMEL, Ireland–(BUSINESS WIRE)–Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutical company, has…
Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality Committee, utilizing his expertise…
NEWARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today…
PORTLAND, Ore., April 22, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the…
SEATTLE, April 22, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary…
CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies,…
Urges Stockholders to Vote the WHITE Proxy Card “FOR” ALL of Adverum’s Three Highly Qualified, Diverse and Independent Directors: Dawn…
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under…
Lille, France; Cambridge, MA; April 22, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
Management to host conference call today at 5:00 pm ETAUSTIN, Texas, April 22, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc.…
